Eris buys 70% stake in Swiss Parenterals

Feb13,2024



New Delhi: Aris Lifesciences Is get a 51% bet In swiss parenteralA sterile injection The manufacturer, for Rs 637.5 crore, to expand its footprint in the sterile injectables business.
The company's promoter group will acquire an additional 19% stake in the company for Rs 237.5 crore, taking the total stake held by Eris and its promoter group in the company to 70%, a company statement said.
The promoter group includes the company's CMDs, Amit Bakshi and Inderjit Singh Negi, Kaushal Shah and Rajendra Patel, among others, the BSE filing said.



Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *